HIV DNA integration

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 7, 2012, Pages

  Craigie, Robert ^a   Bushman, Frederic D ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; INTEGRASE; LENS EPITHELIUM DERIVED GROWTH FACTOR; PROTEIN P75; SMALL INTERFERING RNA; VIRUS DNA; VIRUS NUCLEOPROTEIN; XRCC4 PROTEIN; LENS EPITHELIUM-DERIVED GROWTH FACTOR; SIGNAL PEPTIDE;

ARTICLE; DNA BASE COMPOSITION; DNA END JOINING REPAIR; DNA INTEGRATION; DNA METHYLATION; DNA TRANSPOSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTONE MODIFICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN DNA INTERACTION; PROTO ONCOGENE; SPUMA VIRUS; TRANSESTERIFICATION; VIRION; VIRUS MORPHOLOGY; VIRUS REPLICATION; CELL NUCLEUS; CHEMISTRY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION; REVIEW; VIRUS DNA CELL DNA INTERACTION;

CELL NUCLEUS; DNA, VIRAL; HIV; HIV INTEGRASE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; REVERSE TRANSCRIPTION; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 84867398216     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006890     Document Type: Article

References (133)

1. Arts EJ, Hazuda DJ. 2011. HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a007161.
2. Baekelandt V, Claeys A, Cherepanov P, De Clercq E, De Strooper B, Nuttin B, Debyser Z. 2000. DNA-dependent protein kinase is not required for efficient lentivirus integration. J Virol 74: 11278-11285.
3. Baltimore D. 1970. RNA-dependent DNA polymerase in virions of RNA tumor viruses. Nature 226: 1209-1211.
4. Barr SD, Ciuffi A, Leipzig J, Shinn P, Ecker JR, Bushman FD. 2006. HIV integration site selection: Targeting in macrophages and the effects of different routes of viral entry. Mol Ther 14: 218-225.
5. Berry C, Hannenhalli S, Leipzig J, Bushman FD. 2006. Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol 2: e157. doi: 10. 1371/journal. pcbi. 0020157.
6. Bor YC, Bushman F, Orgel L. 1995. In vitro integration of human immunodeficiency virus type 1 cDNA into targets containing protein-induced bends. Proc Natl Acad Sci 92: 10334-10338.
7. Bowerman B, Brown PO, Bishop JM, Varmus HE. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev 3: 469-478.
8. + T cells infected in culture. AIDS 23: 1461-1471.
9. Brady T, Lee YN, Ronen K, Malani N, Berry CC, Bieniasz PD, Bushman FD. 2009b. Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev 23: 633-642.
10. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926.
11. Brown PO, Bowerman B, Varmus HE, Bishop JM. 1987. Correct integration of retroviral DNA in vitro. Cell 49: 347-356.
12. Brown PO, Bowerman B, Varmus HE, Bishop JM. 1989. Retroviral integration: Structure of the initial covalent complex and its precursor, and a role for the viral IN protein. Proc Natl Acad Sci 86: 2525-2529.
13. Bujacz G, Jaskolski M, Alexandratos J, Wlodawer A, Merkel G, Katz RA, SkalkaAM. 1995. High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J Mol Biol 253: 333-346.
14. Bukovsky A, Gottlinger H. 1996. Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease. J Virol 70: 6820-6825.
15. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley GW, Stevenson M. 1993. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci 90: 6125-6129.
16. Bushman FD. 2001. Lateral DNA transfer: Mechanisms and consequences. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. Bushman FD, Craigie R. 1992. Integration of human immunodeficiency virus DNA: Adduct interference analysis of required DNA sites. Proc Natl Acad Sci 89: 3458-3462.
18. Bushman FD, Fujiwara T, Craigie R. 1990. Retroviral DNA integration directed by HIV integration protein in vitro. Science 249: 1555-1558.
19. Bushman FD, Engelman A, Palmer I, Wingfield P, Craigie R. 1993. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci 90: 3428-3432.
20. Bushman F, Lewinski M, Ciuffi A, Barr S, Leipzig J, Hannenhalli S, Hoffmann C. 2005. Genome-wide analysis of retroviral DNA integration. Nat Rev Microbiol 3: 848-858.
21. Cai M, Zheng R, Caffrey M, Craigie R, Clore GM, Gronenborn AM. 1997. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat Struct Biol 4: 567-577.
22. Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, et al. 2010. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 467: 318-322.
23. Cherepanov P, Maertens G, Proost P, Devreese B, Van Beeumen J, EngelborghsY, De Clercq E, Debyser Z. 2003. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 278: 372-381.
24. Cherepanov P, Ambrosio AL, Rahman S, Ellenberger T, Engelman A. 2005. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator 75. Proc Natl Acad Sci 102: 17308-17313.
25. Chiu TK, Davies DR. 2004. Structure and function of HIV-1 integrase. Curr Top Med Chem 4: 965-977.
26. Christ F, Voet A, Marchand A, Nicolet S, Desimmie BA, Marchand D, Bardiot D, Van der Veken NJ, Van Remoortel B, Strelkov SV, et al. 2010. Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. Nat Chem Biol 6: 442-448.
27. Ciuffi A, Bushman FD. 2006. Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet 22: 388-395.
28. Ciuffi A, Llano M, Poeschla E, Hoffmann C, Leipzig J, Shinn P, Ecker JR, Bushman F. 2005. A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11: 1287-1289.
29. Ciuffi A, Mitchell RS, Hoffmann C, Leipzig J, Shinn P, Ecker JR, Bushman FD. 2006. Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. Mol Ther 13: 366-373.
30. Coffin JM, Hughes SH, Varmus HE. 1997. Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
31. Craig NL, Craigie R, Gellert M, Lambowitz AM. 2002. Mobile DNA II. ASM Press, Washington, DC.
32. Craigie R, Fujiwara T, Bushman F. 1990. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 62: 829-837.
33. Daniel R, Katz RA, Skalka AM. 1999. A role for DNA-PK in retroviral DNA integration. Science 284: 644-647.
34. Dar MJ, Monel B, Krishnan L, Shun MC, Di Nunzio F, Helland DE, Engelman A. 2009. Biochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase. Retrovirology 6: 94.
35. Davies DR, Goryshin IY, Reznikoff WS, Rayment I. 2000. Three-dimensional structure of the Tn5 synaptic complex transposition intermediate. Science 289: 77-85.
36. De Rijck J, Vandekerckhove L, Gijsbers R, Hombrouck A, Hendrix J, Vercammen J, Engelborghs Y, Christ F, Debyser Z. 2006. Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication. J Virol 80: 11498-11509.
37. De Rijck J, Bartholomeeusen K, Ceulemans H, Debyser Z, Gijsbers R. 2010. High-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region. Nucleic Acids Res 38: 6135-6147.
38. Donehower LA, Varmus HE. 1984. A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration. Proc Natl Acad Sci 81: 6461-6465.
39. Du Z, Ilyinskii PO, Lally K, Desrosiers RC, Engelman A. 1997. A mutation in integrase can compensate for mutations in the simian immunodeficiency virus att site. J Virol 71: 8124-8132.
40. Dyda F, Hickman AB, Jenkins TM, Engelman A, Craigie R, Davies DR. 1994. Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases. Science 266: 1981-1986.
41. Eijkelenboom APAM, Puras Lutzke RA, Boelens R, Plasterk RHA, Kaptein R, Hard K. 1995. The DNA binding domain of HIV-1 integrase has an SH3-like fold. Nature Struct Biol 2: 807-810.
42. Eijkelenboom APAM, van den Ent FMI, Vos A, Doreleijers JF, Hard K, Tullius T, Plasterk RHA, Kaptein R, Boelens R. 1997. The solution structure of the amino-terminal HHCC domain of HIV-2 integrase; A three-helix bundle stabilized by zinc. Cur Biol 1: 739-746.
43. Ellison VH, Abrams H, Roe T, Lifson J, Brown PO. 1990. Human immunodeficiency virus integration in a cell-free system. J Virol 64: 2711-2715.
44. Emiliani S, Mousnier A, Busschots K, Maroun M, Van Maele B, Tempe D, Vandekerckhove L, Moisant F, Ben-Slama L, Witvrouw M, et al. 2005. Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J Biol Chem 280: 25517-25523.
45. Engelman A, Craigie R. 1992. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol 66: 6361-6369.
46. Engelman A, Mizuuchi K, Craigie R. 1991. HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer. Cell 67: 1211-1221.
47. Engelman A, Maramorosch K, Murphy FA, Shatkin AJ. 1999. In vivo analysis of retroviral integrase structure and function. In Advances in virus research. Academic Press, San Diego.
48. Farnet CM, Haseltine WA. 1990. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc Natl Acad Sci 87: 4164-4168.
49. Farnet CM, Haseltine WA. 1991a. Circularization of human immunodeficiency virus type 1 DNA in vitro. J Virol 65: 6942-6952.
50. Farnet CM, Haseltine WA. 1991b. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J Virol 65: 1910-1915.
51. Fassati A. 2006. HIV infection of non-dividing cells: A divisive problem. Retrovirology 3: 74.
52. Ferris AL, Wu X, Hughes CM, Stewart C, Smith SJ, Milne TA, Wang GG, Shun MC, Allis CD, Engelman A, et al. 2010. Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration. Proc Natl Acad Sci 107: 3135-3140.
53. Fujiwara T, Craigie R. 1989. Integration of mini-retroviral DNA: A cell-free reaction for biochemical analysis of retroviral integration. Proc Natl Acad Sci 86: 3065-3069.
54. Fujiwara T, Mizuuchi K. 1988. Retroviral DNA integration: Structure of an integration intermediate. Cell 54: 497-504.
55. Ge H, Si Y, Roeder RG. 1998. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J 17: 6723-6729.
56. Gijsbers R, Ronen K, Vets S, Malani N, De Rijck J, McNeely M, Bushman FD, Debyser Z. 2010. LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol Ther 18: 552-560.
57. Grandgenett DP, Vora AC, Schiff RD. 1978. A 32, 000-dalton nucleic acid-binding protein from avian retrovirus cores possesses DNA endonuclease activity. Virology 89: 119-132.
58. Greene WC, Peterlin BM. 2002. Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat Med 8: 673-680.
59. Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, MartinacheC, Rieux-Laucat F, Latour S, Belohradsky BH, et al. 2010. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 363: 355-364.
60. Hare S, Shun MC, Gupta SS, Valkov E, Engelman A, Cherepanov P. 2009. A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modified PSIP1/LEDGF/p75. Plos Pathogens5. doi: 10. 1371/journal. ppat. 1000259.
61. Hare S, Gupta SS, Valkov E, Engelman A, Cherepanov P. 2010. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 464: 232-236.
62. Hindmarsh P, Ridky T, Reeves R, Andrake M, Skalka AM, Leis J. 1999. HMG protein family members stimulate human immunodeficiency virus type 1 avian sarcoma virus concerted DNA integration in vitro. J Virol 73: 2994-3003.
63. Holman AG, Coffin JM. 2005. Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc Natl Acad Sci 102: 6103-6107.
64. Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, KempskiH, Brugman MH, Pike-Overzet K, Chatters SJ, de Ridder D, et al. 2008. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118: 3143-3150.
65. Hu W-S, Hughes SH. 2011. HIV reverse transcription: Virally encoded enzyme. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006882.
66. Jaskolski M, Alexandratos JN, Bujacz G, Wlodawer A. 2009. Piecing together the structure of retroviral integrase, an important target in AIDS therapy. FEBS J276: 2926-2946.
67. Jeanson L, Subra F, Vaganay S, Hervy M, Marangoni E, Bourhis J, Mouscadet JF. 2002. Effect of Ku80 depletion on the preintegrative steps of HIV-1 replication in human cells. Virology 300: 100-108.
68. Jenkins TM, Hickman AB, Dyda F, Ghirlando R, Davies DR, Craigie R. 1995. Catalytic domain of human immunodeficiency virus type 1 integrase: Identification of a soluble mutant by systematic replacement of hydrophobic residues. Proc Natl Acad Sci 92: 6057-6061.
69. Jordan A, Defechereux P, Verdin E. 2001. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J 20: 1726-1738.
70. Ju G, Skalka AM. 1980. Nucleotide sequence analysis of the long terminal repeat (LTR) of avian retroviruses: Structural similarities with transposable elements. Cell 22: 379-386.
71. Katz RA, Merkel G, Kulkosky J, Leis J, Skalka AM. 1990. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63: 87-95.
72. Katz RA, Gravuer K, Skalka AM. 1998. A preferred target DNA structure for retroviral integrase in vitro. J Biol Chem 273: 24190-24195.
73. Katzman M, Katz RA, Skalka AM, Leis J. 1989. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J Virol 63: 5319-5327.
74. Kilzer JM, Stracker TH, Beitzel B, Meek K, Weitzman MD, Bushman FD. 2003. Roles of host cell factors in circularization of retroviral DNA. Virology 314: 460-467.
75. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, TuBP, De Jesus PD, Lilley CE, et al. 2008. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135: 49-60.
76. Krishnan L, Li XA, Naraharisetty HL, Hare S, Cherepanov P, Engelman A. 2010. Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc Natl Acad Sci 107: 15910-15915.
77. Kulkosky J, Jones KS, Katz RA, Mack JPG, Skalka AM. 1992. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol 12: 2331-2338.
78. Lander E. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921.
79. Leavitt AD, Shiue L, Varmus HE. 1993. Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. J Biol Chem 268: 2113-2119.
80. Lee MS, Craigie R. 1998. Protection of retroviral DNA from autointegration: Involvement of a cellular factor. Proc Natl Acad Sci 95: 1528-1533.
81. Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, et al. 2010. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 7: 221-233.
82. Lewinski M, Bisgrove D, Shinn P, Chen H, Verdin E, Berry CC, Ecker JR, Bushman FD. 2005. Genome-wide analysis of chromosomal features repressing HIV transcription. J Virol 79: 6610-6619.
83. Lewinski MK, Yamashita M, Emerman M, Ciuffi A, Marshall H, Crawford G, Collins F, Shinn P, Leipzig J, Hannenhalli S, et al. 2006. Retroviral DNA integration: Viral and cellular determinants of target-site selection. PLoS Pathog 2: e60. doi: 10. 1371/journal. ppat. 0020060.
84. Li M, Craigie R. 2005. Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration. J Biol Chem 280: 29334-29339.
85. Li L, Olvera JM, Yoder K, Mitchell RS, Butler SL, Lieber MR, Martin SL, BushmanFD. 2001. Role of the non-homologous DNA end joining pathway in retroviral infection. EMBO J 20: 3272-3281.
86. Li M, Mizuuchi M, Burke TR Jr., Craigie R. 2006. Retroviral DNA integration: Reaction pathway and critical intermediates. EMBO J 25: 1295-1304.
87. Llano M, Saenz DT, Meehan A, Wongthida P, Peretz M, Walker WH, Teo W, Poeschla EM. 2006a. An essential role for LEDGF/p75 in HIV integration. Science 314: 461-464.
88. Llano M, Vanegas M, Hutchins N, Thompson D, Delgado S, Poeschla EM. 2006b. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75. J Mol Biol 360: 760-773.
89. Lodi PJ, Ernst JA, Kuszewski J, Hickman AB, Engelman A, Craigie R, Clore GM, Gronenborn AM. 1995. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry 34: 9826-9833.
90. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, Debyser Z, Engelborghs Y. 2003. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 278: 33528-33539.
91. Maertens GN, Hare S, Cherepanov P. 2010. The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature 468: 326-329.
92. Marshall H, Ronen K, Berry C, Llano M, Sutherland H, Saenz D, Bickmore W, Poeschla E, Bushman F. 2007. Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS One 2: e1340. doi: 10. 1371/journal. pone. 0001340.
93. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR, Bushman FD. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: pE234. doi: 10. 1371/journal. pbio. 0020234.
94. Mizuuchi K. 1992. Polynucleotidyl transfer reactions in transpositional DNA recombination. J Biol Chem 287: 21273-21276.
95. Mizuuchi K, Adzuma K. 1991. Inversion of the phosphate chirality at the target site of Mu-DNA strand transfer-Evidence for a one-step transesterification mechanism. Cell 66: 129-140.
96. Molteni V, Greenwald J, Rhodes D, Hwang Y, Kwiatkowski W, Bushman FD, Siegel JS, Choe S. 2001. Identification of a small molecule binding site at the dimer interface of the HIV integrase catalytic domain. Acta Crystallogr D 57: 536-544.
97. Murphy JE, Goff SP. 1992. A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo. J Virol 66: 5092-5095.
98. Murphy JE, De Los Santos T, Goff SP. 1993. Mutational analysis of the sequences at the termini of the Moloney murine leukemia virus DNA required for integration. Virology 195: 432-440.
99. Narezkina A, Taganov KD, Litwin S, Stoyanova R, Hayashi J, Seeger C, SkalkaAM, Katz RA. 2004. Genome-wide analyses of avian sarcoma virus integration sites. J Virol 78: 11656-11663.
100. Panganiban AT, Temin HM. 1983. The terminal nucleotides of retrovirus DNA are required for integration but not virus production. Nature 306: 155-160.
101. Panganiban AT, Temin HM. 1984. The retrovirus pol gene encodes a product required for DNA integration: Identification of a retrovirus int locus. Proc Natl Acad Sci 81: 7885-7889.
102. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586.
103. Pruss D, Bushman FD, Wolffe AP. 1994. Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc Natl Acad Sci 91: 5913-5917.
104. Pryciak PM, Varmus HE. 1992. Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69: 769-780.
105. Pryciak PM, Sil A, Varmus HE. 1992. Retroviral integration into minichromosomes in vitro. EMBO J 11: 291-303.
106. Rice P, Craigie R, Davies DR. 1996. Retroviral integrases and their cousins. Curr Opin Struct Biol 6: 76-83.
107. Richardson JM, Colloms SD, Finnegan DJ, Walkinshaw MD. 2009. Molecular architecture of the Mos1 paired-end complex: The structural basis of DNA transposition in a eukaryote. Cell 138: 1096-1108.
108. Roe T, Reynolds TC, Yu G, Brown PO. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12: 2099-2108.
109. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. 2002. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529.
110. Schwartzberg P, Colecilli J, Goff SP. 1984. Construction and analysis of deletion mutations in the pol gene of Moloney murine leukemia virus: A new viral function required for productive infection. Cell 37: 1043-1052.
111. Shimotohno K, Mizutani S, Temin HM. 1980. Sequence of retrovirus provirus resembles that of bacterial transposable elements. Nature 285: 550-554.
112. Shoemaker CS, Goff S, Giboa E, Paskind M, Mitra SW, Baltimore D. 1980. Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: Implications for retrovirus integration. Proc Natl Acad Sci 77: 3932-3936.
113. Shun MC, Raghavendra NK, Vandegraaff N, Daigle JE, Hughes S, Kellam P, Cherepanov P, Engelman A. 2007. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev 21: 1767-1778.
114. Silvers RM, Smith JA, Schowalter M, Litwin S, Liang ZH, Geary K, Daniel R. 2010. Modification of integration site preferences of an HIV-1-based vector by expression of a novel synthetic protein. Hum Gene Ther 21: 337-349.
115. Sinha S, Pursley MH, Grandgenett DP. 2002. Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors. J Virol 76: 3105-3113.
116. Sinha S, Grandgenett DP. 2005. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells. J Virol 79: 8208-8216.
117. Stevens SW, Griffith JD. 1994. Human immunodeficiency virus type 1 may preferentially integrate into chromatin occupied by L1Hs repetitive elements. Proc Natl Acad Sci 91: 5557-5561.
118. Suzuki Y, Craigie R. 2007. The road to chromatin-Nuclear entry of retroviruses. Nat Rev Microbiol 5: 187-196.
119. Temin HM. 1976. The DNA provirus hypothesis. Science 192: 1075-1080.
120. Temin H, Mizutani S. 1970. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226: 1211-1213.
121. Turlure F, Devroe E, Silver PA, Engelman A. 2004. Human cell proteins and human immunodeficiency virus DNA integration. Front Biosci 9: 3187-3208.
122. Turlure F, Maertens G, Rahman S, Cherepanov P, Engelman A. 2006. A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res 34: 1653-1665.
123. van Gent DC, Oude Groeneger AAM, Plasterk RHA. 1992. Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proc Natl Acad Sci 89: 9598-9602.
124. Varmus HE, Brown PO, Berg DE, Howe MM. 1989. Retroviruses. In Mobile DNA, pp. 53-108. American Society for Microbiology, Washington, DC.
125. Venter JC. 2001. The sequence of the human genome. Science 291: 1304-1351.
126. Wang JY, Ling H, Yang W, Craigie R. 2001. Structure of a two-domain fragment of HIV-1 integrase: Implications for domain organization in the intact protein. EMBO J 20: 7333-7343.
127. Wang GP, Ciuffi A, Leipzig J, Berry CC, Bushman FD. 2007. HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res 17: 1186-1194.
128. Weiss R, Teich N, Varmus H, Coffin J. 1984. RNA tumor viruses. Cold Spring Harbor Press, Cold Spring Harbor, NY.
129. Wu X, Li Y, Crise B, Burgess SM. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.
130. Wu X, Li Y, Crise B, Burgess SM, Munroe DJ. 2005. Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses. J Virol 79: 5211-5214.
131. Yoder K, Bushman FD. 2000. Repair of gaps in retroviral DNA integration intermediates. J Virol 74: 11191-11200.
132. Yoder K, Sarasin A, Kraemer K, McIlhatton M, Bushman F, Fishel R. 2006. The DNA repair genes XPB and XPD defend cells from retroviral infection. Proc Natl Acad Sci 103: 4622-4627.
133. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, et al. 2008. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4: 495-504.